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ABSTRACT
Aim To evaluate whether the histology and grading of
solitary pulmonary nodules (SPNs) correlated with the
results of dynamic multiphase multidetector CT (MDCT)
and the [
18F]ﬂuorodeoxyglucose standardised uptake
value (SUV) in 30 patients.
Methods Chest x-rays of 270 patients with incidentally
detected SPNs were retrospectively evaluated. Thirty
patients with histologically proven SPNs were enrolled.
On MDCT and positron emission tomography (PET)/CT
images, two experts measured the density of nodules in
all perfusion phases and the SUV. Net enhancement (NE)
was calculated by subtracting peak pre-contrast density
from peak post-contrast density. The Pearson test was
used to correlate nodule NE, SUV, grading, histology and
diameter.
Results Of the 30 malignant SPNs, six were classiﬁed
as G1 (median NE, 31.5 Hounsﬁeld units (HU); median
SUV, 4.8 units), 15 were classiﬁed as G2 (median NE, 49
HU; median SUV, 6 units), and nine were classiﬁed as G3
(median NE, 32 HU; median SUV, 4.5 units). A highly
negative correlation was found in G3 SPNs between NE
and the corresponding diameters (r¼ 0.834;
p¼0.00524). NE increased with the increase in diameter
(r¼0.982; p¼0.284). SUV increased as the SPN
diameter increased (r¼0.789; p¼0.421). NE and SUV
were higher in G2 than G1 SPNs, and lower in G2 than
G3 SPNs (r¼0.97; p¼0.137).
Conclusions The signiﬁcant correlation in
dedifferentiated (G3) SPNs between NE and diameter
(r¼ 0.834; p¼0.00524) supports the theory that
stroma and neoangiogenesis are fundamental in SPN
growth. The highly negative correlation between NE and
diameter demonstrates a net decrease in perfusion
despite an increase in dimension. The multidisciplinary
approach used herein may result in a more precise
prognosis and consequently a better therapeutic
outcome, particularly in patients with undifferentiated
lung cancer.
INTRODUCTION
Characterisation of solitary pulmonary nodules
(SPNs)isamajorclinicalandradiologicalconcern;in
fact, the overall incidence of malignancy in SPNs is
30e40%ofcases.
1e7IntheUSA,w150000SPNsare
detected each year with a progressive positive trend
due to incidental ﬁndings on chest CT, which is
widely used in oncological screening and follow-up.
SPNs are ﬁrst detected on chest radiography. CT,
[
18F]ﬂuorodeoxyglucose (FDG) positron emission
tomography (PET) and MRI are subsequently used
to distinguish between benign and malignant
nodules.
8e12 The prevalence of malignancy in SPNs
correlates with SPN dimensions: 0e1% in 5 mm
nodules; 6e28% in nodules of 5e10 mm; 64e82%
in nodules over 20 mm.
2 Various radiological
studies have shown that the histopathology of
SPNs varies greatly, and malignancies account for
about 60e80% of cases.
61 3 e15
The aim of this study was to evaluate whether
there was a correlation between the histology and
grading of SPNs and the results of dynamic multi-
phase multidetector CT (MDCT) and the
18F-FDG
standardised uptake value (SUV) in 30 patients.
MATERIALS AND METHODS
The chest x-rays of 270 patients with incidentally
detected SPNs (10e30 mm) were retrospectively
evaluated. From these, the imaging sets of 153
patients who underwent MDCT and PET/CT
within 30 days of chest x-rays were selected. Forty-
eight of these patients had multiple lung nodules,
whereas MDCT data were incomplete in 34. Forty-
one SPNs <3 cm with a typical pattern of benign
lesions such as macrocalciﬁcations or a cystic
pattern were excluded. Thus, 123 patients were
excluded from the study. In conclusion, 30 patients
(24 men, six women, mean age 67 years, range
54e86) were included in the study.
Image acquisition
All images were acquired with a 16-slice scanner
(Brilliance 16; Philips, Eindhoven, The Netherlands)
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Original articleusing 120 kV, 300 mA, 1631.25 pitch, 2 mm-thick slice and
1 mm gap. A pre-contrast acquisition followed by multiple post-
contrast scans were obtained using dynamic acquisitions at 1, 2,
3 and 4 min after intravenous administration of 1.5 ml/kg non-
ionic iodinated contrast medium (NICM; 350 mg/ml iodine).
Three-dimensional PETwas performed from feet to head 60 min
after intravenous administration of
18F-FDG (4.5 MBq/kg). An
integrated PET/CT scanner (Biograph 16; Siemens, Erlangen,
Germany) consisting of an ultrafast CT scanner, with a 16-row
multislice detector system, and a PET scanner, equipped with
a full-ring lutetium oxyorthosilicate system and a crystal size of
4.4 mm
2, was used.
CTwas performed in spiral mode. Data acquisition began with
CTusing 120 kV, 110e115 mA, 2 mm pitch and 1 s tube rotation,
and these data were used for the correction of densitometric
values of attenuation. Emission scan bed time was 3 min,
resulting in a total PET scan time of 20e25 min (seven or eight
bed positions), with axial image planes at a 16.2 cm axial ﬁeld-
of-view per position. After attenuation and scatter correction of
PET data, images were reconstructed using an attenuation-
weighted ordered-subsets maximisation expectation approach
with two iterations and eight subsets on a 1283128 matrix and
5 mm Gaussian post-ﬁltering.
Image analysis
All CT images were re-evaluated using a workstation, and
densitometric measurements of SPNs were recorded in all
contrastographic phases. To standardise recording values,aregion
of interest was drawn inside nodules, avoiding calciﬁed inclu-
sions, vessels, bronchogram or colliquative areas. Densitometry
was evaluated along the equatorial plane of each lesion to cover
almost 70% of the lesion. Net enhancement (NE) was evaluated
by subtracting pre-contrast density from the peak density
obtained from post-contrast values. PET/CT images were
reconstructed on a Leonardo (Siemens Medical Solutions)
workstation. A lesion was considered positive on the basis of
visual judgement of the degree of increased glucose metabolism
relating to mediastinum activity by two experienced, indepen-
dent interpreters, supported by semiquantitative evaluation
based on the calculation of the SUVof
18F-FDG-PET.
Statistical analysis
The correlation between dimensions, enhancement, SUV,
grading and histological ﬁndings of SPNs was determined with
the Pearson test; a correlation was deﬁned when p<0.05 with 2
degrees of freedom.
RESULTS
As shown in table 1, morphological evaluation of SPNs revealed
spiculated margins in 24/30 (72.8%) nodules and lobulated
margins in 6/30 (26.2%). SPN diameter was 21e30 mm in 22/30
(73%) patients, 11e20 mm in 7/30 (23%) and <11 mm in 1/30
(4%). The median diameter of G1, G2 and G3 SPNs was 20.5 mm,
26 mm and 23 mm, respectively (ﬁgure 1). The histological
diagnosis was lung cancer in all 30 patients: adenocarcinoma
in 18/30 (60%) patients, epidermoid carcinoma in 6/30 (20%),
carcinoid in 2/30 (6.7%), and small cell lung cancer in 4/30
(13.3%).
Of the 30 malignant SPNs, six were classiﬁed as G1 (well
differentiated (ﬁgure 2); median NE, 31.5 Hounsﬁeld units (HU);
Table 1 Overview of the patients and tumours evaluated in this study
Patient Sex Diameter (mm) Histology Pre-CT Post-CT NE PET/SUV Grade Margins
1 M 20 Carcinoid 18 60 42 4.01 G1 Lobulated
2 M 20 Carcinoid 19 35 16 6.53 G1 Lobulated
3 M 22 Adenocarcinoma 25 83 58 7.14 G1 Spiculated
4 M 21 Adenocarcinoma 15 55 40 3.05 G1 Spiculated
5 F 22 Adenocarcinoma 10 26 16 4.50 G1 Spiculated
6 F 20 Adenocarcinoma 7 30 23 5.10 G1 Spiculated
7 M 14 Adenocarcinoma 27 54 27 6.03 G2 Spiculated
8 M 15 Adenocarcinoma 46 98 52 6.03 G2 Spiculated
9 M 29 Adenocarcinoma 50 105 55 6.03 G2 Spiculated
10 F 29 Adenocarcinoma 47 90 43 3.45 G2 Spiculated
11 M 30 Adenocarcinoma 22 69 47 3.67 G2 Spiculated
12 M 30 Adenocarcinoma 32 87 55 2.55 G2 Spiculated
13 M 22 Adenocarcinoma 14 77 63 3.50 G2 Spiculated
14 M 25 Adenocarcinoma 28 58 30 5.80 G2 Spiculated
15 F 28 Adenocarcinoma 38 87 49 8.50 G2 Spiculated
16 M 26 Adenocarcinoma 48 65 17 4.40 G2 Spiculated
17 M 30 Epidermoid 34 86 52 38.22 G2 Spiculated
18 M 25 Epidermoid 17 82 65 10.20 G2 Spiculated
19 M 30 Epidermoid 75 98 23 19.50 G2 Spiculated
20 M 24 Epidermoid 42 102 60 2.10 G2 Spiculated
21 F 23 Epidermoid 39 60 21 22.40 G2 Spiculated
22 M 9.5 Adenocarcinoma 5 48 43 2.05 G3 Lobulated
23 M 22.5 Adenocarcinoma 12 44 32 12.50 G3 Lobulated
24 F 14 SCLC 57 94 37 0.10 G3 Lobulated
25 M 27 SCLC 25 47 22 5.50 G3 Lobulated
26 M 14 Adenocarcinoma 18 62 44 0.10 G3 Spiculated
27 M 28 Adenocarcinoma 43 69 26 8.13 G3 Spiculated
28 M 23 Adenocarcinoma 18 44 26 7.50 G3 Spiculated
29 M 27 SCLC 19 41 22 4.59 G3 Spiculated
30 M 26 SCLC 38 75 37 2.90 G3 Spiculated
E, net enhancement; SCLC, small cell lung cancer; SUV, standardised uptake value.
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Original articlemedian SUV, 4.8 units (ﬁgures 3 and 4)), 15 were classiﬁed as G2
(moderately differentiated (ﬁgure 5); median NE, 49 HU; median
SUV, 6 units (ﬁgures 3 and 4)), and nine were classiﬁed as G3
(poorly differentiated (ﬁgure 6); median NE, 32 HU; median SUV,
4.5 units (ﬁgures 3 and 4)). NE was >15 HU in all patients. SUV
was <2.5 units in four patients and >2.5 units in 26 patients.
The Pearson correlation test revealed a highly negative corre-
lation in G3 SPNs between NE and their corresponding diame-
ters (r¼ 0.834 and p¼0.00524) (ﬁgure 7). Analysis of the
correlation between SPN dimensions, NE, SUV, grading and
histological ﬁndings showed that the NE of malignant SPNs
increased with an increase in diameter (r¼0.982; p¼0.284). Also
the SUV increased as the SPN diameter increased (r¼0.789;
p¼0.421). In addition, NE and SUV were higher in G2 than
G1 SPNs, and lower in G2 than G3 SPNs (r¼0.97; p¼0.137).
p Values >0.05 were probably due to the low number of patients
enrolled in the study.
DISCUSSION
Evaluation of morphological aspects is usually the ﬁrst step in
diagnosing SPNs.
3 Margins are considered important, usually
being well deﬁned in benign lesions and irregular and/or spicu-
lated in malignant lesions. However, about 20e30% of SPNs
with well-deﬁned margins are diagnosed as malignant.
45
Moreover, the margins of many nodules are classiﬁed as inde-
terminate, and diagnosis remains a dilemma.
Figure 1 Median diameters of single pulmonary nodules according to
grade.
Figure 2 Adenocarcinoma in a 69-year-old woman. The post-contrast axial scan shows a transverse thin section (2.0 mm collimation) on a 20 mm
nodule (arrow) with spiculated margins (A,B). After placement of a superimposed region of interest, the post-contrast image shows an enhancement of
30 Hounsﬁeld units (HU) at 4 min and a net enhancement of 23 HU. The solitary pulmonary nodule has an area of [
18F]ﬂuorodeoxyglucose uptake with
a maximum standardised uptake value of 5.10 units; fusion images on axial sagittal and coronal planes show this captation area (C,D). This lesion was
classiﬁed as a well-differentiated (G1) adenocarcinoma with low vascularity, poor necrosis and moderate cellularity (E).
Figure 3 Net enhancement in G1, G2 and G3 single pulmonary nodules.
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Original articleThe advent of dynamic MDCT and PET/CT in the early
1990s
8 represented a breakthrough in oncology, particularly with
regard to identiﬁcation and characterisation of SPNs.
6 MDCT
and PET/CT, unlike biopsy, videothoracoscopy and surgical
resection, are non-invasive procedures. The rationale of this
method is based on the abnormal and anarchic vascularisation of
malignant SPNs that sustains the fast rate of tumour growth.
CT scans with NICM readily detect vascular structures.
7 The
efﬁciency of dynamic CT in the characterisation of SPNs is
well established, although different modalities of technical
execution and cut-off values have been used to identify malig-
nant SPNs.
57 e91 71 8We carry out MDCT examinations using
the protocol CTof Swensen et al
8 and dynamic volumetric scans
1, 2, 3 and 4 min after NICM administration. This procedure has
sensibility, speciﬁcity and accuracy values of 98%, 58% and 77%
in differentiating benign from malignant SPNs.
8 It has been
reported that scans acquired 15 min after NICM injection
showed contrast medium washout, differentiating among
benign nodules those with high enhancement, active granu-
lomas and vascular lesions, and also differentiating among
malignant nodules, thereby increasing speciﬁcity.
5 However,
despite potential beneﬁt in terms of speciﬁcity, in order to limit
the patients’ exposure to radiation, we did not carry out scans
15 min after NICM administration.
9
PET is a nuclear medicine technique based on the pharmaco-
dynamics of the
18F-FDG radiotracer that enters neoplastic
nodules. SUV is the ratio between the amount of radiotracer
taken up by a lesion and the amount of radiotracer that would
hypothetically be present in a region of equal volume if the
tracer was uniformly distributed throughout the body. A SUVof
>2.5 units is highly predictive of malignancy. At a SUV of
$2.5 units, PET has a sensitivity and speciﬁcity of 77% and
100%, respectively.
12 Very few studies have used SUV cut-offs of
$3.3
13 14 and $5.5 units,
15 which have lower sensitivity and
speciﬁcity values than >2.5 or <2.5 units. Integrated with
MDCT, PET has a sensitivity, speciﬁcity and accuracy of 96%,
88% and 93%, respectively, in identifying malignant SPNs.
16
PET/CT alone cannot detect nodules of <1 cm, carcinoids or
bronchioalveolar carcinomas.
12 A strong correlation has recently
been reported between contrast enhancement and microvessel
density
19 20 and between SUV and histological ﬁndings.
19 21
Therefore, CTand PET/CTcan play a relevant role in evaluating
the response to treatment, particularly if considered together
with histology and grading.
Figure 4 Median [
18F]ﬂuorodeoxyglucose standardised uptake value
(SUV) in G1, G2 and G3 single pulmonary nodules.
Figure 5 Adenocarcinoma in a 79-year-old man. Post-contrast CT axial scan shows a transverse thin section (2.0 mm collimation) on a 30 mm
nodule (arrow) with spiculated margins (A,B). A superimposed region of interest on post-contrast images at 4 min shows an enhancement of 87
Hounsﬁeld units (HU) and a net enhancement of 55 HU. The solitary pulmonary nodule has an area of [
18F]ﬂuorodeoxyglucose uptake, with a maximum
standardised uptake value of 2.55 units. The positron emission tomography image integrated with the CT image to obtain fusion images on axial
sagittal and coronal planes shows the captation site (C,D). This lesion was classiﬁed as a moderately differentiated (G2) adenocarcinoma with rich
vascularity, moderate necrosis, low hypercellularity and moderate connective stroma (E).
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Original articleThis is the ﬁrst study to look at the relationship between CT
enhancement, SUV and histopathological grading of SPNs.
Grading is the most accurate biological indicator of disease
activity and a fundamental prognostic factor because the degree
of cellular differentiation predicts relapse and/or metastasis
development. Patients with undifferentiated lung cancer were
reported to have an 80% risk of death, whereas patients with
poorly differentiated or moderately differentiated lung cancer
have a risk of death of 70% and 40%, respectively.
22
In our study, G2 SPNs were the largest lesions (median
26.5 mm), G1 were the smallest (median 20 mm) and G3 SPNs
were slightly larger than G1 SPNs (median 23 mm) but smaller
than G2 SPNs. Median NE and SUV were higher in G2 than G1
SPNs and lower in G3 than G2 SPNs. We found a signiﬁcant
negative correlation between NE and lesion diameter in G3
SPNs, demonstrating a net decrease of perfusion in dediffer-
entiated (G3) SPNs, particularly when compared with G2 SPNs.
This observation supports the ﬁnding of Wang et al
23 that CT
enhancement may reﬂect tumour angiogenesis. In addition,
as mentioned above, immunochemical studies have demon-
strated a correlation between enhancement and microvessel
density in SPNs.
19 20 There are various reports of a signiﬁcant
decrease in microvessel density going from G1 to G3 renal cell
carcinomas due to architectural remodelling of vascularity
inﬂuenced by tumour progression.
24e27 Diverse mechanisms
have been evoked to explain this behaviour: the inability of
neovascularisation to keep pace with a high proliferation of
tumour cells causes a decrease in architectural complexity, and
the tumour becomes hypoxic and necrotic; and the develop-
ment of ﬁbrosis and large vascular channels within the tumour
would have the effect of decreasing microvessel density without
necessarily altering the total vascular area and blood supply.
According to Vaupel,
28 the most highly vascularised regions
within the tumour may not reﬂect the dedifferentiated grade:
a relevant percentage of tumour vascularisation may be
temporarily non-functional because of the development of
thromboses and shunts. Similar physiopathological principles
could explain the SUV trend identiﬁed in this study: cellular
proliferation seems to be reduced with the decrease in vascular
stroma and the increase in ﬁbrosis, inducing a proportionally
lower uptake of
18F-FDG, especially in G3 SPNs. However,
while this mechanism could explain the lower SUVin G3 versus
G2 SPNs, it does not explain the higher SUV in G2 versus G1
and G3 SPNs.
Figure 6 Adenocarcinoma in a 71-year-old man. Post-contrast CT axial scan shows a transverse thin section (2.0 mm collimation) on a 9.5 mm
nodule (arrow) with lobulated margins (A,B). A superimposed region of interest shows an enhancement of 48 Hounsﬁeld units (HU) and a net
enhancement of 43 HU. The solitary pulmonary nodule has a standardised uptake value of 2.05 units; fusion images obtained on the axial sagittal and
coronal planes show the captation areas (C,D). This lesion was classiﬁed as a poorly differentiated (G3) adenocarcinoma with moderate vascularity,
low necrosis and hypercellularity and moderate connective stroma (E).
Figure 7 Scatterplot of the correlation between net enhancement (NE)
and median diameter of G3 single pulmonary nodules.
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Original articleIn conclusion, our data on NE and SUV in G1, G2 and G3
SPNs support the theory that stroma and neoangiogenesis are
fundamental in the growth of SPNs, above all in G3 SPNs where
the highly negative correlation between NE and the corre-
sponding diameters demonstrate a net decrease in perfusion
despite the increase in dimensions.
21 29 Our data indicate that
the multidisciplinary approach used in this study may result in
a more precise prognosis and consequently a better therapeutic
outcome, particularly in patients with undifferentiated lung
cancer. However, owing to the small number of patients in our
study, it is difﬁcult to identify clinically important results.
Therefore, studies with larger numbers of patients and more
histological subtypes are required to determine the full potential
and clinical impact of the combined use of MDCT, PET/CTand
grading in evaluating SPNs.
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Take-home messages
< CT net enhancement (NE) well explains the growing
characteristics of solitary pulmonary nodules (SPNs), which
are strictly related to their angiogenesis activity.
< G3-graded SPNs showed reduced CT NE compared with G2
lesions; this behaviour reﬂects a structural anarchy in
vascularisation that is pronounced in G3 lesions.
< Similar trends in [
18F]ﬂuorodeoxyglucose (
18F-FDG) stand-
ardised uptake value (SUV) and CT NE values can be identiﬁed
between G1/G2 and G3 lesions; although each technique
strictly deﬁned a different phenomenon, respectively vascu-
larisation and metabolic activity, such behaviours show the
close relationships that link contrast medium delivery and
18F-FDG consumption in SPNs.
< A comprehensive evaluation of NE and
18F-FDG SUV in clinical
routine would probably lead to an accurate evaluation of
potential SPN aggressiveness.
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